Skip to content

3D Ultrasound Breast Imaging

3D Multimodal Ultrasound Imaging for Breast Cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04692818
Enrollment
125
Registered
2021-01-05
Start date
2021-11-10
Completion date
2026-12-31
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Tumor

Brief summary

The purpose of this research is to study the efficacy of a new ultrasound imaging method for diagnosis of breast mass.

Interventions

DIAGNOSTIC_TESTGE Logiq E10 clinical ultrasound scanner

2D B-mode, Doppler, and shear wave elastography images of the lesion

DIAGNOSTIC_TESTVerasonics research scanner

3D B-mode imaging, microvessel imaging, and shear wave elastography

Sponsors

Mayo Clinic
Lead SponsorOTHER
United States Department of Defense
CollaboratorFED

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult women ≥ 18 years of age. * solid breast lesion and ultrasound guided biopsy (either as part of their clinical care or through participation in other IRB-approved studies) * lesion size of 3mm or larger

Exclusion criteria

* \< 18 years of age. * Lacking capacity to consent * Pregnant or lactating * Receiving cancer therapy such as chemotherapy or radiation therapy

Design outcomes

Primary

MeasureTime frameDescription
BI-RADS ScoreBaselineBI-RADS scores will be obtained using 2D B-mode ultrasound images from the GE Logiq E10 clinical scanner, and using 3D B-mode images from the Verasonics scanner. A 7-point BI-RADS scale will be used, with a score of 1, 2, or 3 considered negative and 4a, 4b, 4c, and 5 considered positive.

Countries

United States

Contacts

CONTACTBobbie Ott
Ott.Bobbie@mayo.edu507-293-0922
PRINCIPAL_INVESTIGATORShigao Chen, PhD

Mayo Clinic

PRINCIPAL_INVESTIGATORChristine Lee, MD, PhD

Mayo Clinic in Rochester

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 2, 2026